VC Magazin

Bildnachweis: NavVis. NavVis (München) hat eine Finanzierungsrunde in Höhe von 85 Mio. USD abgeschlossen, die von der US-amerikanischen Private-Equity-Gesellschaft The Jordan Company angeführt wurde. An der Runde beteiligten sich außerdem …

Bildnachweis: Anchor Rechtsanwälte. Das US-amerikanische Life-Sciences-Unternehmen Bruker übernimmt die DISQVER-Plattform sowie ausgewählte Vermögenswerte der insolventen Noscendo GmbH. Das Diagnostik-Startup aus Duisburg wird im Rahmen einer übertragenen

Dubai is feeling a certain restraint in tourism and the property sector. At the same time, the government continues to systematically expand its start-up strategy. Anyone seeking to understand the market must therefore not only look at short-term market r

The US start-up ecosystem is highly dynamic, with capital and talent increasingly spreading beyond Silicon Valley into new hubs, as investor Konstantin Marquardt explains in this interview. Through the family office Tangram, he focuses on applied AI and d

The 2026 European Deep Tech Report, published by Lakestar, Walden Catalyst, and Dealroom, places Switzerland at the top of Europe's deep tech landscape. ETH Zurich is the global leader for alumni-founded deeptech start-ups, producing 192 companies since 2

Event Recap: Deep Dive Life Sciences brings together industry leaders in Munich - EY Report, BioM Report and Panel discussion.

The Strüngmann Award has entered its decisive phase with the announcement of the three finalists for the 2026 edition.

Prompted by the European competitiveness agenda of Letta/Draghi, the EU Commission presented a proposal on 18 March 2026 for a Regulation on an optional uniform legal form in EU company law designated as

PwC Germany's 'Scale Program Cloud in Healthcare' connects investors, corporates, hospitals, and B2B healthtech start-ups to accelerate clinically validated innovation. Simplants, part of the programme, is developing a data-driven platform for medtech pro

Fresh capital and a strategic pivot: how Ulm-based deeptech company NVision is transforming from a sensing hardware provider into a holistic 'compute and validate' platform for the pharmaceutical industry.